# Adjuvant Intravitreal Bevacizumab in Pars Plana Vitrectomy for Diabetic Vitreous Hemorrhage

> **NCT01151722** · PHASE2 · UNKNOWN · sponsor: **University of Sao Paulo** · enrollment: 2 (estimated)

## Conditions studied

- Recurrent
- Hemorrhage

## Interventions

- **PROCEDURE:** bevacizumab injection
- **PROCEDURE:** bevacizumab injection

## Key facts

- **NCT ID:** NCT01151722
- **Lead sponsor:** University of Sao Paulo
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2009-12
- **Primary completion:** 2010-12
- **Final completion:** —
- **Target enrollment:** 2 (ESTIMATED)
- **Last updated:** 2010-06-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01151722

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01151722, "Adjuvant Intravitreal Bevacizumab in Pars Plana Vitrectomy for Diabetic Vitreous Hemorrhage". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT01151722. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*